As Nvidia reports, here's the history of what happens next after ten giant stocks outperform
For those who stick around, thanks, and here's some Nvidia-related insight. It comes courtesy of the fund manager AllianceBernstein, which looked at periods where the top 10 stocks dominated over the ...
TJX's earnings boosted by strength in Europe as earnings beat and retailer raises guidance
The company is now expecting full-year EPS to range from $4.15 to $4.17, up from prior guidance of $4.09 to $4.13. It still expects same-store sales to rise 3%, but raised its pretax profit margin ...
U.K. Inflation Rebounds Above Bank of England Target; China Holds Benchmark Lending Rates Steady
China held its benchmark lending rates steady , a highly anticipated move following a steep cut to borrowing costs last month. Major Chinese lenders kept 1-year and 5-year loan prime rates steady at 3 ...
TJX's earnings top estimates and company raises guidance
Inc.'s stock (TJX) rose slightly early Wednesday, after the discount retailer's fiscal third-quarter earnings topped estimates and it raised guidance. The company had net income of $1.297 billion, or ...
Nio's stock dives as earnings, outlook disappoint despite record deliveries
The U.S.-listed shares of Nio Inc. took a dive in early Wednesday trading, after the China-based battery electric-vehicle maker reported disappointing third-quarter results, as they missed ...
Sage Therapeutics to end Huntington's disease trial after key therapy fails again
Sage Therapeutics Inc.'s stock (SAGE) fell 2% early Wednesday after the company said it would cease the development of a treatment for cognitive impairment associated with Huntington's disease after a ...
Pfizer names oncology chief and company veteran Boshoff as chief scientific officer
Pfizer Inc. (PFE) named oncology chief and company veteran Chris Boshoff as its new chief scientific officer on Wednesday, replacing Mikael Dolsten starting Jan. 1.